Background Image
Table of Contents Table of Contents
Previous Page  18 / 64 Next Page
Information
Show Menu
Previous Page 18 / 64 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 3, May/June 2020

126

AFRICA

Comparison of TDI parameters measured from the lateral

mitral annulus (m) demonstrated similar S

, E

and A

velocities;

E/E

ratios; ejection time and isovolumetric contraction time;

isovolumetric relaxation time; and myocardial performance

index among the three groups (Table 3). The treatment groups

(IVA and LPC) had significantly higher ejection time and

isovolumetric relaxation time, and lower E

velocity, measured at

the septal part of the mitral annulus, than the control group (

p

< 0.001), whereas S

and A

velocity, isovolumetric contraction

time and MPI were similar. In addition, A

velocity derived

from the lateral tricuspid annulus was significantly higher in the

treatment groups than in the control group (

p

= 0.007), whereas

S

and E

velocity, ejection time, isovolumetric contraction time,

isovolumetric relaxation time and MPI were similar. On the

other hand, A

velocity measured from the lateral tricuspid

annulus was not significantly different between the IVA and

LPC groups.

DI and strain values were significantly lower in the treatment

groups (LPC and IVA) than in the control group (

p

< 0.05) (Table

4, Fig. 2). SI values were significantly higher in comparison with

the control group (

p

< 0.05) (Table 4). There was no statistically

significant difference in aortic elastic parameters between the

LPC and IVA groups.

Intra-observer reproducibility of aortic measurements was

calculated after the re-evaluation of randomly selected images of

31 patients and 20 controls, and the results were 2.2 and 2.6%,

respectively, for AoD, 3.1 and 3.4%, respectively, for AoS, 2.2 and

2.6%, respectively, for DI, and 3.4 and 3.1%, respectively, for SI.

Table 1. Clinical features of the study groups

Demographic

features

LPC group

(

n

= 15)

IVA group

(

n

= 16)

Control

(

n

= 20)

p

-value

Age (months)

17 ± 4.4

14.4 ± 4.9

14.5 ± 2.8

0.257

Gender (

n

, %)

Male

4 (26.7)

9 (56.3)

8 (40)

0.245

Female

11 (73.3)

7 (43.8)

12 (60)

Weight (kg)

10.1 ± 1.4

9.6 ± 2.1

9.86 ± 0.3

0.743

Height (cm)

78.2 ± 6.1

78.1 ± 10.2

78.3 ± 0.57 0.999

GA (weeks)

29.8 ± 2.7

29.3 ± 2.9

29.5 ± 2.8

0.641

BW (g)

1464 ± 451

1279 ± 320

1352 ± 394 0.196

HR (beats/min)

127.5 ± 14.9

137.7 ± 20.8

139.8 ± 11.9 0.208

SBP (mmHg)

84 ± 9.7

(70–102)

90 ± 6.7

(80–105)

86 ± 9.0

(72–102)

0.971

DBP (mmHg)

48 ± 5.3

(41–60)

48 ± 6.1

(39–65)

49 ± 7.9

(39–63)

0.147

PMA at treat-

ment (weeks)

35.3 ± 1.66

(32–38)

35.5 ± 1.64

(32–37)

0.972

Time of echo

(months)

13.2 ± 2.8

12.9 ± 2.3

0.125

Data are presented as the mean values ± SD.

Student’s

t

-test, Kruskal–Wallis test:

p

< 0.05 considered statistically significant.

GA: gestational age, BW: birth weight, HR: heart rate, SBP: systolic blood pres-

sure, DBP: diastolic blood pressure, LPC: laser photocoagulation, IVA: intravit-

real aflibercept, PMA: postmenstrual age, IVI: intravitreal injection.

Table 2. M-mode echocardiographic parameters of the study groups

M-mode measurements

LPC group

(

n

= 15)

IVA group

(

n

= 16)

Control

(

n

= 20)

p

-value

IVSd (mm)

0.54 ± 0.09 0.51 ± 0.06 0.52 ± 0.04 0.656

IVSs (mm)

0.56 ± 0.09 0.6 ± 0.08 0.54 ± 0.04 0.192

LVIDd (mm)

2.58 ± 0.25 2.5 ± 0.36 2.57 ± 0.23 0.150

LVIDs (mm)

1.59 ± 0.19 1.5 ± 0.19 1.51 ± 0.13 0.249

LVPWd (mm)

0.43 ± 0.04 0.45 ± 0.06 0.43 ± 0.04 0.584

LVPWs (mm)

0.74 ± 0.08 0.78 ± 0.18 0.75 ± 0.07 0.871

EF (%)

70.9 ± 3.6 71.9 ± 4.2 72.8 ± 3.96 0.466

FS (%)

38.5 ± 3.1 39.6 ± 3.8 40.3 ± 4.1 0.535

MAPSE (cm)

10.0 ± 0.56 10.3 ± 0.99 11.1 ± 1.3 0.020*

TAPSE (cm)

17 ± 1.21 16.3 ± 2.2 16.4 ± 1.58 0.661

Data are presented as the mean values ± SD.

One-way analysis of variance (ANOVA) or Kruskal–Wallis tests: *

p

< 0.05

considered statistically significant.

IVSs: interventricular septum systolic thickness, IVSd: interventricular septum

diastolic thickness, LVIDd: left ventricular end-diastolic diameter, LVIDs: left

ventricular end-systolic diameter, LVPWd: left ventricle posterior wall diastolic

dimension, LWPWs: left ventricle posterior wall systolic dimension, EF: ejec-

tion fraction, FS: fractional shortening, MAPSE: mitral annular plane systolic

excursion, TAPSE: tricuspid annular plane systolic excursion.

Table 3. Conventional and tissue Doppler echocardiographic

parameters of the study groups

‘Pulsed’ and tissue

‘pulsed’ Doppler

measurements

Group 1

(LPC) (

n

= 15)

Group 2

(IVA) (n = 16 )

Controls

(

n

= 20) p-value

Mitral E (cm/s)

98 ± 8.2

98 ± 14

98 ± 13 0.970

Mitral A (cm/s)

69 ± 11

65 ± 12

60 ± 7.2 0.834

Mitral E/A

1.66 ± 0.31

1.65 ± 0.34

1.65 ± 0.25 0.901

Tricuspid E (cm/s)

74 ± 6.0

78 ± 10

70 ± 16 0.037*

#

Tricuspid A (cm/s)

47 ± 8.2

46 ± 11

44 ± 6.6 0.511

Tricuspid E/A

1.55 ± 0.24

1.55 ± 0.24

1.72 ± 0.41 0.428

Sm (cm/s)

7.7 ± 1.9

7.8 ± 1.47

7.4 ± 0.99 0.261

E’m (cm/s)

10.8 ± 1.3

10.4 ± 1.0

12.4 ± 1.4 0.004*

A’m (cm/s)

7.2 ± 1.3

7.2 ± 2.8

7.2 ± 1.06 0.871

ETm (ms)

213.3 ± 16.5

195.6 ± 33.0 185.4 ± 18.3 0.007*

IVCTm (ms)

48.8 ± 7.6

46.1 ± 8.5

47.7 ± 7.1 0.488

IVRTm (ms)

48.3 ± 5.42

44.6 ± 5.88

41.0 ± 4.44 0.002*

MPIm (Tei index)

0.45 ± 0.04

0.49 ± 0.08

0.47 ± 0.03 0.560

E/E

m

8.02 ± 2.03

8.02 ± 2.05

8 ± 1.67 0.900

Ss (cm/s)

6.7 ± 1.9

6.7 ± 1.0

7 ± 0.97 0.766

E

s (cm/s)

11.8 ± 4.8

9.7 ± 3.0

10.6 ± 3.8 0.182

A

s (cm/s)

7.2 ± 1.3

6.6 ± 1.89

7.4 ± 2.2 0.516

ETs (ms)

207.2 ± 27.2

197.3 ± 32.5 193.2 ± 25 0.061

IVCTs (ms)

47 ± 4.6

45 ± 7.6

42.5 ± 7.01 0.174

IVRTs (ms)

43.6 ± 5.4

44.6 ± 5.6

43 ± 6.0 0.236

MPIs (Tei index)

45 ± 4.3

46.1 ± 5.6

44.5 ± 6.21 0.792

E/E

s

9.8 ± 2.05

9.8 ± 2.05

8.8 ± 2.0 0.230

Sr (cm/s)

9 ± 4.4

9.4 ± 4.2

8.7 ± 5.3 0.755

E

r (cm/s)

13.1 ± 3.8

14.6 ± 2.1

14.5 ± 2.03 0.515

A

r (cm/s)

10.1 ± 2.0

11 ± 2.0

8.8 ± 1.0 0.007*

ETr (ms)

210.1 ± 15.8

202.1 ± 27.8 195.8 ± 27.5 0.379

IVCTr (ms)

49.2 ± 5.8

46.3 ± 10

46.8 ± 9.68 0.663

IVRTr (ms)

51.3 ± 5.9

50 ± 8.1

46.5 ± 7.9 0.211

MPIr (Tei index)

45.0 ± 4.3

46.5 ± 6

47.5 ± 5.1 0.815

E/E

r

6.8 ± 1.18

6.8 ± 1.18

6.88 ± 1.09 0.673

Data are presented as the mean values ± SD.

One-way analysis of variance (ANOVA) or Kruskal–Wallis tests: *

p

< 0.05

considered statistically significant,

#

p

< 0.05 (LPC vs IVA, Mann–Whitney

U

-test).

A

: late diastolic myocardial velocity, E

: early diastolic myocardial veloc-

ity, S: systolic myocardial velocity, ET: ejection time, IVCT: isovolumetric

contraction time, IVRT: isovolumetric relaxation time, MPI: myocardial perfor-

mance index, m: lateral mitral annulus, r: lateral tricuspid annulus, s: septal

mitral annulus.

Table 4. Comparison of aortic elasticity parameters of the study groups

Elasticity parameters

LPC group

(

n

= 15)

IVA group

(

n

= 16)

Control

(

n

= 20)

p

-value

Aortic strain

16.2 ± 4.4 16.7 ± 3.9 22.6 ± 4.5 0.018*

Stiffness index

3.4 ± 0.7

3.6 ± 0.6

2.2 ± 0.3 0.036*

Distensibility index

8.2 ± 1.6

8.0 ± 1.8 11.6 ± 2.4

0.025*

Data are presented as the mean values ± SD

One-way analysis of variance (ANOVA) or Kruskal–Wallis tests: *

p

< 0.05

considered statistically significant.